Your browser doesn't support javascript.
loading
Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician's Survey in the Middle East.
Ammoury, Alfred; Hegazy, Rehab; Al Talhab, Saad; Ameen, Ahmed; Hassan, Nehal; Ghoubar, Marcelle.
Afiliação
  • Ammoury A; Saint George Hospital University Medical Center, Beirut, Lebanon.
  • Hegazy R; Cairo University Hospital, Cairo, Egypt.
  • Al Talhab S; Imam Mohammad Ibn Saud Islamic University, Riyadh, Saudi Arabia.
  • Ameen A; NMC Specialty Hospital, Abu Dhabi, United Arab Emirates.
  • Hassan N; Pfizer Egypt LLC, Cairo, Egypt.
  • Ghoubar M; Pfizer Gulf FZ LLC, Sin El Fil, Beirut, Lebanon. marcelle.ghoubar@pfizer.com.
Dermatol Ther (Heidelb) ; 13(8): 1801-1815, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37354294
INTRODUCTION: Alopecia areata (AA) is an autoimmune disease characterized by nonscarring hair loss involving the scalp, face, and/or body. Literature on the prevalence, patient characteristics, management approaches, and challenges faced by patients with AA across the Middle East is limited. Therefore, a greater understanding of the current AA landscape within the region is needed. This cross-sectional study surveyed dermatologists from four countries to assess dermatologists' perspectives on the prevalence of AA within the Middle East, as well as patient characteristics, unmet needs, and management strategies. METHODS: This blinded, quantitative, observational study surveyed practicing dermatologists in Egypt, Lebanon, Saudi Arabia, and the United Arab Emirates. The survey was conducted between September 2021 and January 2022 and comprised 47 closed-ended, multiple-choice questions as well as Likert scale responses. These questions assessed the characteristics of physicians and the patients in their practices, physicians' familiarity with treatment, and physicians' treatment approaches. RESULTS: The estimated prevalence of AA varied across the region. Across all age groups treated for AA, the majority of patients had AA of mild severity (pediatric: 63%; adolescent: 60%; adult: 54%) and the scalp was reported as the most affected area (65%). Potent topical corticosteroids were the most frequently used treatment for mild to moderate and severe AA (92% and 78%, respectively). There was a lack of awareness of investigative treatments, with only 33% of dermatologists aware of these options. The greatest unmet needs in treating AA included long-term disease control, improved efficacy, faster onset of action, and better safety profiles (62%, 53%, 52%, and 51%, respectively). CONCLUSIONS: This study provided insight into the diagnosis and management of AA in the Middle East. Treatment strategies were similar regardless of the severity of AA. Long-term disease control and improved efficacy and safety profiles were identified as key unmet needs in the treatment of AA.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Dermatol Ther (Heidelb) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Líbano País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Dermatol Ther (Heidelb) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Líbano País de publicação: Suíça